Document is current
Any future updates will be listed below
-
Authors
Hawkins, Neil https://orcid.org/0000-0003-3199-221X
Hazra, Aniruddha https://orcid.org/0000-0001-8557-4465
Brizzi, Marisa https://orcid.org/0000-0002-6986-2042
Thompson, Juliette https://orcid.org/0000-0001-7646-9460
Grove, Richard https://orcid.org/0000-0002-5722-4406
Sieverding, Marius https://orcid.org/0000-0002-2178-4743
Budnik, Piotr https://orcid.org/0009-0009-4344-2822
Scherzer, Jenny
Danchenko, Natalya
Anderson, Sarah-Jane
Dupont-Benjamin, Laure https://orcid.org/0000-0001-7748-0768
-
Funding
Funding for this research was provided by:
ViiV Healthcare
- License Information
-
More Information
Article History
Received: 27 October 2025
Accepted: 27 March 2026
First Online: 22 May 2026
Declarations
:
: Neil Hawkins and Juliette Thompson have received consulting fees from ViiV Healthcare. Aniruddha Hazra has contracts for clinical research unrelated to this work from Gilead and has received consulting fees from Abbott Technologies, Gilead, and ViiV Healthcare. Marisa Brizzi has received payment or honoraria for speakers bureaus from Gilead and ViiV Healthcare and participated on an advisory board for Gilead, Merck, and ViiV Healthcare. Richard Grove is an employee of GSK and holds stock in GSK. Marius Sieverding has no conflicts to disclose. Piotr Budnik is an employee of ViiV Healthcare and owns stock in GSK and Haleon. Jenny Scherzer and Natalya Danchenko are employees of ViiV Healthcare and may own stock in GSK. Sarah-Jane Anderson is an employee of GSK and owns stock in GSK and Haleon. Laure Dupont-Benjamin is an employee of ViiV Healthcare; owns stock in AbbVi.e., GSK, and Haleon; and is receiving consulting fees from the International Union Against Tuberculosis and Lung Disease.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
